You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.

Open menu

News

MHRA grants marketing authorisation for Global Blood Therapeutics’s Oxbryta

Global Blood Therapeutics (GBT) has announced that the Medicines and Healthcare products Regulatory Agency (MHRA) has granted Britain marketing authorisation for Oxbryta – also known as voxelotor.